Acutaas Chemicals Ltd
NSE:ACUTAAS

Watchlist Manager
Acutaas Chemicals Ltd Logo
Acutaas Chemicals Ltd
NSE:ACUTAAS
Watchlist
Price: 1 623.2 INR -1.68%
Market Cap: 132.9B INR

Acutaas Chemicals Ltd
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Acutaas Chemicals Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Acutaas Chemicals Ltd
NSE:ACUTAAS
Net Income (Common)
₹1.6B
CAGR 3-Years
30%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Net Income (Common)
₹57.7B
CAGR 3-Years
23%
CAGR 5-Years
29%
CAGR 10-Years
15%
Cipla Ltd
NSE:CIPLA
Net Income (Common)
₹54.4B
CAGR 3-Years
28%
CAGR 5-Years
24%
CAGR 10-Years
12%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Net Income (Common)
₹104.5B
CAGR 3-Years
37%
CAGR 5-Years
48%
CAGR 10-Years
14%
Lupin Ltd
NSE:LUPIN
Net Income (Common)
₹43.2B
CAGR 3-Years
299%
CAGR 5-Years
N/A
CAGR 10-Years
7%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Net Income (Common)
₹21.4B
CAGR 3-Years
39%
CAGR 5-Years
12%
CAGR 10-Years
4%
No Stocks Found

Acutaas Chemicals Ltd
Glance View

Market Cap
132.9B INR
Industry
Pharmaceuticals

Acutaas Chemicals Ltd. engages in the development and commercialization of pharmaceutical intermediate products and specialty chemicals. The company is headquartered in Surat, Gujarat. The company went IPO on 2021-09-14. The company is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other industries. The company manufactures pharma intermediates for certain active pharmaceutical ingredients (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. The company has developed and commercialized over 520 plus products, including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas since inception and NCE across select high-growth high margin chronic therapeutic areas.

ACUTAAS Intrinsic Value
HIDDEN
Show

See Also

What is Acutaas Chemicals Ltd's Net Income (Common)?
Net Income (Common)
1.6B INR

Based on the financial report for Mar 31, 2025, Acutaas Chemicals Ltd's Net Income (Common) amounts to 1.6B INR.

What is Acutaas Chemicals Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
42%

Over the last year, the Net Income (Common) growth was 271%. The average annual Net Income (Common) growth rates for Acutaas Chemicals Ltd have been 30% over the past three years , 42% over the past five years .

Back to Top